IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candid…
Biotechnology
US, South San Francisco [HQ]
IDYA/Financial Reporting
Income Statements
Profit & Loss · 7 Statements · From 2023 to 2017Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | - - | - - | - - | 19.00 | 27.00 | 50.00 | 23.00 | |
|
EPS
|
-0.83 | -2.41 | -1.90 | -1.31 | -1.35 | -1.32 | -1.96 | |
| Diluted in mil. | -0.83 | -2.41 | -1.90 | -1.31 | -1.35 | -1.32 | -1.96 | |
|
Profit
|
- - | - - | -1.00 | -20.00 | 26.00 | 48.00 | 19.00 | |
| Gross Margin | - - | - - | - - | -103.18 | 93.83 | 95.87 | 82.86 | |
| Pre Tax | -11.00 | -34.00 | -41.00 | -34.00 | -49.00 | -58.00 | -112.00 | |
| Profit Margin | - - | - - | - - | -176.55 | -178.10 | -115.17 | -483.05 | |
| ETR | 1.26 | -6.03 | 8.42 | 6.46 | 4.48 | 6.56 | - - | |
| Net | -11.00 | -34.00 | -38.00 | -32.00 | -47.00 | -54.00 | -112.00 | |
| Profit Margin | - - | - - | - - | -165.14 | -170.11 | -107.61 | -483.05 | |
| EBITDA | -14.00 | -35.00 | -44.00 | -35.00 | -50.00 | -62.00 | -130.00 | |
| EBITDA Margin | - - | - - | - - | -180.90 | -179.91 | -122.72 | -557.71 | |
| Operating Income | -14.00 | -36.00 | -44.00 | -35.00 | -50.00 | -62.00 | -134.00 | |
| Operating Margin | - - | - - | - - | -180.90 | -179.91 | -122.72 | -574.85 | |
| Interest Income | - - | 1.00 | 2.00 | - - | - - | 3.00 | 21.00 | |
| Loss | -14.00 | -36.00 | -44.00 | -54.00 | -78.00 | -113.00 | -157.00 | |
| Cost of Revenue | - - | - - | -1.00 | -39.00 | -1.00 | -2.00 | -4.00 | |
|
Operating Expenses
|
-14.00 | -36.00 | -44.00 | -54.00 | -78.00 | -113.00 | -157.00 | |
| R&D | -12.00 | -31.00 | -34.00 | -39.00 | -58.00 | -89.00 | -129.00 | |
| G&A | -2.00 | -4.00 | -9.00 | -15.00 | -20.00 | -23.00 | -28.00 | |
| SG&A | -2.00 | -4.00 | -9.00 | -15.00 | -20.00 | -23.00 | -28.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | -1.00 | -1.00 | -1.00 | -2.00 | -4.00 | |
| Interest Expenses | - - | - - | - - | - - | - - | -3.00 | -21.00 | |
| Other Expenses | -2.00 | - - | -2.00 | - - | - - | -3.00 | -21.00 | |
|
WA Shares Outstanding
|
14.00 | 14.00 | 20.00 | 24.00 | 35.00 | 41.00 | 57.00 | |
| Diluted | 14.00 | 14.00 | 20.00 | 24.00 | 35.00 | 41.00 | 57.00 |